Glucagon-like peptide 1 (GLP-1) is a hormone that triggers the release of insulin, inhibits the secretion of glucagon to prevent blood sugar levels rising, slows the emptying of the stomach and increases satiety
Likewise, a 2010 phase III, randomized, double-blind, placebo-controlled, parallel-group study undertaken in Europe found that MT1 reduced the severity of PLE when administered as a 16 mg implant over a four-month period [14]
**If you are very sensitive in the eye area, begin only using this product very sparingly every other day or so
Xing, C
However, like any medical treatment, they can come with side effects, including nausea, vomiting, diarrhea, and constipation